SOLVE-TAVI after 12-month followup: self-expanding vs. balloon expandable and general vs. local anesthesia

The ambitious SOLVE-TAVI (soon to be published in JACC) is aimed at answering to of the most important questions we make when facing a TAVR procedure: What valve do we choose, a self-expanding or a balloon expandable? And once we have chosen our device, do we proceed with general anesthesia or conscious sedation? 

Sedación consciente vs anestesia general en el TAVI

 

The SOLVE-TAVI had already shown no major differences at 30 days between devices or sedation strategies. At present, after one year, we look forward to these results. 

Using a 2 × 2 factorial design, 447 intermediate to high-risk patients with severe, symptomatic aortic stenosis were randomly assigned to transfemoral TAVR using the self-expanding Evolut R vs. the balloon expandable Sapien 3.  Following the 2 x 2 design, patients were randomized to general anesthesia vs. conscious sedation at the same time. 

When comparing devices, the combined end point rate (all-cause mortality, stroke, moderate to severe paravalvular leak and need of permanent pacemaker implantation) resulted similar between prosthesis at one year (38.3% vs 40.4%, HR 0.94, CI 95% 0.7 to 1.26; p=0.66).

As regards sedation, outcomes were as disappointing: general anesthesia resulted similar to conscious sedation when it came to the combined end point of all-cause mortality, stroke, MI and acute kidney injury (25.7% vs 23.8%, HR 1.09, CI 95% 0.76 to 1.57; p=0.63).


Read also: TCT 2018 | SOLVE-TAVI: Self-Expandable vs. Balloon-Expandable Valves and General vs. Local Anesthesia in One Study.


Probablemente, para la enorme mayoría de los pacientes la elección de la válvula o el tipo de anestesia todavía pase por la experiencia de cada operador y equipo. Sin embargo, existen diferencias sutiles de subgrupos que pueden inclinar la balanza hacia una u otra válvula como también al tipo de anestesia.

Conclusión

En pacientes de riesgo intermedio o alto que reciben TAVI transfemoral no se observaron diferencias al año entre las actuales generaciones de la válvula autoexpandible y la válvula balón expandible. Los tipos de anestesia tampoco mostraron diferencias significativas en el mismo período de tiempo.

Título original: Impact of Anesthesia Strategy and Valve Type on Clinical Outcomes After Transcatheter Aortic Valve Replacement.

Referencia: Hans-Josef Feistritzer et al. J Am Coll Cardiol. 2021 May, 77 (17) 2204–2215.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

ACC 2026 | Extended follow-up of the TRI-FR study: Edge-to-edge percutaneous repair in isolated severe tricuspid regurgitation

Severe tricuspid regurgitation (TR) is associated with chronic systemic venous congestion, recurrent hospitalizations for heart failure (HF), and a significant deterioration in quality of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...